Friday, March 21, 2025
spot_img

Preferred Bank Announces Dividend Increase

LOS ANGELES, March 19, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the largest independent commercial banks in California, today reported that the Board of Directors has declared a quarterly cash dividend to $0.75 per share, payable on April 21, 2025 to holders of record on April 7, 2025.

About Preferred Bank

Preferred Bank is one of the larger independent commercial banks headquartered in California. The Bank is chartered by the State of California, and its deposits are insured by the Federal Deposit Insurance Corporation, or FDIC, to the maximum extent permitted by law. The Bank conducts its banking business from its main office in Los Angeles, California, and through twelve full-service branch banking offices in the California cities of Alhambra, Century City, City of Industry, Torrance, Arcadia, Irvine (2 branches), Diamond Bar, Pico Rivera, Tarzana and San Francisco (2 branches) and one branch in Flushing, New York and one branch in the Houston suburb of Sugar Land, Texas. Additionally, the Bank operates a Loan Production Office in Sunnyvale, California and a satellite office in Manhattan, New York. Preferred Bank offers a broad range of deposit and loan products and services to both commercial and consumer customers. The Bank provides personalized deposit services as well as real estate finance, commercial loans and trade finance to small and mid-sized businesses, entrepreneurs, real estate developers, professionals and high net worth individuals. Although originally founded as a Chinese-American Bank, Preferred Bank now derives most of its customers from the diversified mainstream market but does continue to benefit from the significant migration to California of ethnic Chinese from China and other areas of East Asia.

AT THE COMPANY:
Edward J. Czajka
Executive Vice President
Chief Financial Officer
(213) 891-1188
AT FINANCIAL PROFILES:
Jeffrey Haas
General Information
(310) 622-8240
[email protected]

Powered by SlickText.com

Hot this week

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 ...

Ordinær generalforsamling 2025

Indkaldelse til ordinær generalforsamling den 23. april 2025 er...

Net Asset Value(s)

FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 NAV ANNOUNCEMENT21 MARCH...

Topics

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 ...

Ordinær generalforsamling 2025

Indkaldelse til ordinær generalforsamling den 23. april 2025 er...

Net Asset Value(s)

FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 NAV ANNOUNCEMENT21 MARCH...

Net Asset Value(s)

                 WisdomTree Issuer plc – Daily Fund Prices 20-March-25        WisdomTree...

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

New Drug Application (NDA) for Dordaviprone as Treatment for...
spot_img

Related Articles

Popular Categories

spot_img